Houston Office
3200 Travis, 3rd Floor
Houston, TX 77006
P: 713-529-0025
F: 713-751-0412

Galveston Office
P: 409-762-9090

Toll Free: 888-529-4628
Email Website

Steinberg Law Firm P.C.

Xeljanz Lawsuit

Xeljanz Lawsuit

Xeljanz Lawsuit

Our law firm is evaluating claims for a Xeljanz Lawsuit. Recent studies of the drug Xeljanz; used to treat rheumatoid or psoriatic arthritis, have shown an increase risk of fatal blood clots in the lungs. Recent injuries and side effects associated with patients prescribed Xeljanz include Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Stroke (Ischemic/Embolic) and other Blood clot injuries. Patients with rheumatoid arthritis that were prescribed 10 mg of Xeljanz twice a day has a statistically significant higher rate of pulmonary embolism (PE) compared to a control group given tumor necrosis factor inhibitors. A post-marketing safety study also concluded that patients that take just 5 mg of Xeljanz have an increased death rate compared to the control group. If you or a loved one has suffered these side effects or injuries after taking the drug Xeljanz, please contact our law firm now as you may be entitled to financial compensation.

What is Xeljanz?

In 2012 the FDA first approved the drug Xeljanz to treat adults with rheumatoid arthritis. The drug was prescribed to block certain enzymes in the body that affects immune system function to treat rheumatoid arthritis. The use of the drug was later expanded in 2017 to treat patients with active psoriatic arthritis (PsA). Again in May 2018, the use of the drug was further expanded to treat patients with moderate to severe ulcerative colitis.

FDA Recent Reports and Warnings

The FDA has recently issued their strongest warning label, placing a "box" prominently on the drug about the high risk of blood clots with use of Xeljanz. The warning from the FDA further recommends patients notifying their doctor or health care professional immediately of any history of blood clots or heart issues prior to taking the drug Xeljanz. If the patient show signs of thrombosis, the FDA is advising that doctors to discontinue prescribing the drug to the patient.

Xeljanz Lawsuit Information:

Lawsuits are currently being evaluated and accepted for individuals who have taken Xeljanz and suffered:

  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Stroke (Ischemic/Embolic)
  • Other Blood Clot Injury
  • Wrongful Death of a Loved One

Consult a Doctor on Medical Issues

Our law firm does not intend, by this web site or otherwise, to dissuade anyone from taking the advice of medical professionals and their doctors. Please consult your doctor, not your lawyer, on matters relating to your health.

If you or a loved one suffered from a blood clot after taking any dose of Xeljanz or Xeljanz XR for ulcerative colitis, rheumatoid arthritis, or psoriatic arthritis, contact us now as you maybe entitled to financial compensation.